MSF challenges Novartis's action over Indian patent for imatinib.
Mudur
Ganapati
G
D000970:Antineoplastic Agents; D001549:Benzamides; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D000068877:Imatinib Mesylate; D007194:India; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D010879:Piperazines; D011743:Pyrimidines
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate